Insulin resistance, defined as the diminished responsiveness of insulin-target tissues to insulin, is the central pathogenic mechanism underlying obesity-associated disorders such as type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), and atherosclerosis [2,3]. This evidence concerns the gene INS and obesity disorder.